Hodgkin's lymphoma in children aged 5 years or less - The United Kingdom experience

European Journal of Cancer

Volumn 43, Issue 9, 2007, Pages 1415-1421

  Stoneham, S ^a   Ashley, S ^b   Pinkerton, Ross ^c   Hewitt, Martin ^d   Wallace, W H B ^e   Shankar, A G ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c MATER CHILDREN S HOSPITAL   (Australia)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

^e ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Hodgkin's lymphoma; Hypothyroidism; Radiotherapy; Relapses; Survival; Young children

Indexed keywords

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; PREDNISOLONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ANAMNESIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HODGKIN DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SALVAGE THERAPY; UNITED KINGDOM;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; GREAT BRITAIN; HODGKIN DISEASE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY; TREATMENT FAILURE;

EID: 34250020792     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.03.013     Document Type: Article

References (28)

1. Kinuthia D.M., and Kasili E.G. Hodgkin's disease in Kenyan children (a six-year report on management). East Afr Med J 57 (1980) 769-780
2. Sutton M. Hodgkin's disease in a child aged 17 months. Br J Clin Pract 26 (1972) 89-90
3. Kung K.F. Hodgkin's disease in children 4 years of age or younger. Cancer 67 (1991) 1428-1430
4. Carbone P.P., Kaplan H.S., Musshoff K., et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res 31 (1971) 1860-1861
5. Lukes R.J., and Butler J.J. The pathology and nomenclature of Hodgkin's disease. Cancer Res 26 (1966) 1063-1083
6. Kaplan E.L., and Meier P. Non-parametric assessment of incomplete observations. J Am Stat Assoc 53 (1958) 457-481
7. Cox D.R. Regression models and life tables. J Roy Stat Soc B 34 (1972) 187-220
8. Harif M., Trachli A., Quessar A., et al. Service d'hematologie et oncologie pediatriques, centre hospitalier lbn Rochd, Casablanca, Maroc. Bull Cancer 83 (1996) 937-939
9. White L., McCourt B.A., Isaacs H., et al. Patterns of Hodgkin's disease at diagnosis in young children. Am J Pediatr Hematol Oncol 5 (1983) 251-257
10. Cleary S.F., Link M.P., and Donaldson S.S. Hodgkin's disease in the very young. Int J Radiat Oncol Biol Phys 28 (1994) 77-83
11. Pao W.J., and Kun L.E. Hodgkin's disease in children. Hematol Oncol Clin North Am 3 (1989) 345-365
12. Pellegrino B., Terrier-Lacombe M.J., Oberlin O., et al. Lymphocyte-predominant Hodgkin's lymphoma in children: therapeutic abstention after initial lymph node resection - a Study of the French Society of Paediatric Oncology. J Clin Oncol 21 (2003) 2948-2952
13. Sandoval C., Venkateswaran L., Billups C., et al. Lymphocyte-predominant Hodgkin disease in children. J Pediatr Hematol Oncol 24 (2002) 269-273
14. Murphy S.B., Morgan E.R., Katzenstein H.M., et al. Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents. J Pediatr Hematol Oncol 25 (2003) 684-687
15. Sklar C., Whitton J., Mertens A., et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 85 (2000) 3227-3232
16. Bhatia S., Robison L.L., Oberlin O., et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. New Engl J Med 334 (1996) 745-751
17. Metayer C., Lynch C.F., Clarke E.A., et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 18 (2000) 2435-2443
18. Le Deley M.C., Leblanc T., Shamsaldin A., et al. Societe Francaise d'Oncologie Pediatrique. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 21 (2003) 1074-1081
19. Bhatia S., Yasui Y., Robison L.L., et al. Late Effects Study Group. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol 21 (2003) 4386-4394
20. Lin H.M., and Teitell M.A. Second malignancy after treatment of paediatric Hodgkin disease. J Pediatr Hematol Oncol 27 (2005) 28-36
21. Abayomi O.K. Neck irradiation, carotid injury and its consequences. Oral Oncol 40 (2004) 872-878
22. Dorresteijn L.D., Kappelle A.C., Scholz N.M., et al. Increased carotid wall thickening after radiotherapy on the neck. Eur J Cancer 41 (2005) 1026-1030
23. Wilimas J., Thompson E., and Smith K.L. Long-term results of treatment of children and adolescents with Hodgkin's disease. Cancer 46 (1980) 2123-2125
24. Oliveira B.M., Viana M.B., and Cunha K.C. Hodgkins disease in childhood: a sixteen year experience in a single institution. Pediatr (Rio J) 76 (2000) 281-286
25. Shankar A.G., Ashley S., Radford M., et al. Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group. J Clin Oncol 15 (1997) 2622-2630
26. Dorffel W., Luders H., Ruhl U., et al. Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook. Klin Padiatr 215 (2003) 139-145
27. Mauz-Koerholz Christine G., Kluge R., Sorge I., et al. Response adapted therapy: using FDG-PET after chemotherapy in order to restrict indication for radiotherapy in children and adolescents with early stages of Hodgkin's lymphoma (HL). Blood 106 (2005) 2672 [ASH Annual Meeting Abstracts]
28. Children's Cancer and Leukaemia Group - United Kingdom. , see Hodgkin's lymphoma protocols.